Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by Infinium Global Research on the equine pharmaceuticals and supplements market provides an in-depth analysis of segments and sub-segments in the global as well as regional equine pharmaceuticals and supplements market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional equine pharmaceuticals and supplements market over the short term as well as long term. The report is a comprehensive presentation of trends, forecasts, and dollar values of the global equine pharmaceuticals and supplements market. According to the report, the global equine pharmaceuticals and supplements market is projected to grow at a CAGR of above 3% over the forecast period of 2022-2028.
The revenue generated by the market was approximately nearly USD 993 million in 2022 and is expected to reach more than USD 1235 million in 2028 and is expected to grow with a CAGR of above 3% till 2028. Nutritional and health supplements are commonly used to help prevent nutrient and mineral deficiencies. Various animal health institutions and governments spreading awareness, about the need for good healthy diets and health supplements for the growth and healthy life of horses. Most of the trainers and breeders of the horses adopt advanced pharmaceutical products, for preventing illness and for healing diseases. In developed and developing nations there has been an increasing number of equine practices and hospitals that provide high levels of specialization in this market.
Growing knowledge of equine pharmaceuticals and supplements products is driving the worldwide equine pharmaceuticals and supplements markets. The health of the horses is very important for sustaining the growth of those sectors. Due to the rising preference for organic products among horse trainers and breeders, demand for herbal digestion, feed, and energy supplements for horses is expected to drive this market. The horseracing sector significantly drives the demand for the equine pharmaceuticals and supplement market. Strict regulations regarding pharmaceutical products and supplements are a major constraint for the market. Identifying the Growing Demands and new technology offers growth opportunities in the equine pharmaceuticals and supplements market. In the equine supplements and pharmaceutical market nanotechnology is used to improve diagnosis and treatment. New opportunities are expected to arise as investments in R&D of new equine pharmaceuticals is growing.
Geographically, the global equine pharmaceutical and supplement market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. Among the geographies, the USA is expected to hold a significant share of the Equine Pharmaceuticals and Supplements market. China drives the growth of the Asia-pacific market with the significant import of horses from other regions for racing and other activities. Asia Pacific is a growing market owing to factors such as technological innovation research and development in the field of equine medicines and supplements. The prevalence of diseases in equines is the major factor driving the growth of the European equine pharmaceutical and supplement market. Horse-exporting nations such as South Africa, Netherlands, Germany, Ireland Belgium, the UK, and France spent heavily on high-quality equine pharmaceuticals and supplements.
The report on the global equine pharmaceuticals and supplements market covers segments such as type and distribution channel. On the basis of type, the sub-markets include pharmaceuticals, and supplements. On the basis of distribution channel, the sub-markets include veterinary hospitals, pharmacies and clinics, drug store, and online.
The report provides profiles of the companies in the market such as Boehringer Ingelheim International GmbH, Dechra Veterinary Products Limited, virbac, Merck & Co., Norbrook, Zoetis, Elanco Animal Health Vetoquinol, Celltrion healthcare co., and Purina animal nutrition LLC.
The report provides deep insights into demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of the equine
pharmaceuticals and supplements market. Moreover, the study highlights current
market trends and provides forecasts from 2022-2028. We also have highlighted
future trends in the market that will affect the demand during the forecast
period. Moreover, the competitive analysis given in each regional market brings insight into the market share of the leading players.
Please Choose One of them.